Virology Symposium
| Monday, May 12, 2008 | ||||
| Program: | ||||
| 9.00 - 9.15: | Stuart Le Grice, HIV DRP, CEHCV | |||
| Welcoming remarks | ||||
| 9.15 - 10.00: | Barry O’Keefe, MTDP | |||
| Novel Antiviral Proteins from Natural Product Extracts: New Leads for Chemoprevention and Therapy | ||||
| 10.00 - 10.15: | Catherine Adamson, HIV DRP | |||
| Viral Resistance to Bevirimat, A Novel HIV-1 Maturation Inhibitor | ||||
| 10.15 - 10.30: | Rachel Bagni, SAIC | |||
| Dendritic Cell-Mediated Infection of Primary B Cells with KSHV | ||||
| 10.30 - 10.45: | Alun Bermingham, MTDP | |||
| Mechanistic Evaluation of Natural Product Inhibitors of HIV-1 RNase H | ||||
| 10.45 - 11.00: | Robert Brinson, HIV DRP | |||
| Neomycin B as a Chemical Probe of Structural Anomalies in Retroviral HIV-1 and LTR-Retrotransoposon Ty3 Polypurine Tract-containing RNA/DNA Hybrids | ||||
| 11.00 - 11.15: | --------- Coffee break --------- | |||
| 11.15 - 11.30: | Nancy Chung, HIV DRP | |||
| Determinants Within the DC-SIGN Carbohydrate Recognition Domain (CRD) are Necessary for HIV-1 Binding and Transmission from B cells | ||||
| 11.30 - 11.45: | Anna Honko, USAMRID | |||
| Title to be announced | ||||
| 11.45 - 12.00: | Christie Vu, HIV DRP | |||
| Evaluation of C4’-alkylated Nucleoside Analogs as HIV-1 Reverse Transcriptase Inhibitors | ||||
| 12.00 - 12.15: | Michal Legiewicz, HIV DRP | |||
| Resistance to RevM10 Inhibition is Accompanied by a Conformational Switch in the HIV-1 Rev Response Element | ||||
| 12.15 - 12.30: | Selinda Orr, LEI | |||
| Title to be announced | ||||
| 12.30 - 1.30: | --------- Lunch break --------- | |||
| 1.30 - 1.45: | Viraj Kulkarni, Vaccine Branch | |||
| DNA Vaccination With Modified Antigens Alters Immune Response to SIV Antigens | ||||
| 1.45 - 2.00: | Suhman Chung, HIV DRP | |||
| Diazirine-based photocrosslinking for the study of the interaction between HIV-1 reverse transcriptase RNase H domain and RNA/DNA hybrids | ||||
| 2.00 - 2.15: | Benjamin Luttge, HIV DRP | |||
| Selection for FIV Resistance to a Dominant-Negative Mutant of Tsg101 | ||||
| 2.15 - 2.30: | Steve Bradfute, USAMRID | |||
| Functional Lymphocyte Responses to Ebola Virus Infection | ||||
| 2.30 - 2.45: | --------- Coffee Break --------- | |||
| 2.45 - 3.00: | Rashmi Jalah, Vaccine Branch | |||
| Electroporation Of Optimized SIV DNA Vaccines With IL-12 DNA As Adjuvant Leads To Greatly Enhanced Immune Responses And Control Of Viremia Upon Challenge. | ||||
| 3.00 - 3.15: | Abdul Waheed, HIV DRP | |||
| Mechanism of Anti-HIV Activity of Cholesterol-binding Compound Amphotericin B Methyl Ester: Inhibition of Assembly/Release exhibits Vpu-dependence | ||||
| 3.15 - 3.30: | Yongpin Yang, SAIC | |||
| In Vivo Potential Effects of Adenovirus Type 5 E1A and E1B on Lung Carcinogenesis and lymphoproliferative Inflammation | ||||
| 3.30 - 3.45: | Raul Cachau, ATP, SAIC | |||
| Raul Cachau, ATP, SAIC | ||||
